Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size

    Article Cited by others

ORIGINAL ARTICLE

Low early posttransplant serum tacrolimus levels are associated with poor patient survival in lung transplant patients

Ryu Jung-Hwa, Choi Sunmi, Lee Hyun Joo, Kim Young Tae, Kim Young Whan, Yang Jaeseok

Year : 2019| Volume: 14| Issue : 3 | Page no: 186-191

   This article has been cited by
 
1 Composite CYP3A phenotypes influence tacrolimus dose-adjusted concentration in lung transplant recipients
Michelle Liu, Ciara M. Shaver, Kelly A. Birdwell, Stephanie A. Heeney, Christian M. Shaffer, Sara L. Van Driest
Pharmacogenetics and Genomics. 2022; Publish Ah
[Pubmed]  [Google Scholar] [DOI]
2 Tacrolimus monitoring parameters are not associated with acute cellular rejection following lung transplantation
Christina C. Kao, Justin Segraves, Amit D. Parulekar
European Journal of Clinical Pharmacology. 2021; 77(1): 63
[Pubmed]  [Google Scholar] [DOI]
3 Calcineurin Inhibitor–Based Maintenance Immunosuppression in Lung Transplant Recipients: Optimal Serum Levels for Managing Acute Rejection and Renal Function
Chelsey M. McPheeters, Douglas Lorenz, Pamela K. Burcham, Christopher D. Barger, Bikash Bhandari, Gerene S. Bauldoff, Daniel B. Truelove, David R. Nunley
Transplantation Proceedings. 2021; 53(6): 1998
[Pubmed]  [Google Scholar] [DOI]

 

Read this article